ORIC Pharmaceuticals Inc [NASDAQ: ORIC] loss -1.25% on the last trading session, reaching $11.04 price per share at the time.
ORIC Pharmaceuticals Inc represents 71.08 million in outstanding shares, while the company has a total market value of $940.88 million with the latest information. ORIC stock price has been found in the range of $10.0 to $11.62.
If compared to the average trading volume of 1.16M shares, ORIC reached a trading volume of 12363083 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about ORIC Pharmaceuticals Inc [ORIC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ORIC shares is $19.10 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ORIC stock is a recommendation set at 1.09. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for ORIC Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 08, 2025. While these analysts kept the previous recommendation, Wells Fargo raised their target price to Overweight. The new note on the price target was released on October 31, 2024, representing the official price target for ORIC Pharmaceuticals Inc stock. Previously, the target price had yet another raise to $20, while Stifel analysts kept a Buy rating on ORIC stock.
The Price to Book ratio for the last quarter was 3.57, with the Price to Cash per share for the same quarter was set at 2.39.
Trading performance analysis for ORIC stock
ORIC Pharmaceuticals Inc [ORIC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.99. With this latest performance, ORIC shares gained by 7.08% in over the last four-week period, additionally plugging by 1.94% over the last 6 months – not to mention a rise of 36.80% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ORIC stock in for the last two-week period is set at 56.49, with the RSI for the last a single of trading hit 0.67, and the three-weeks RSI is set at 0.66 for ORIC Pharmaceuticals Inc [ORIC]. The present Moving Average for the last 50 days of trading for this stock 9.47, while it was recorded at 11.44 for the last single week of trading, and 8.45 for the last 200 days.
ORIC Pharmaceuticals Inc (ORIC) Capital Structure & Debt Analysis
According to recent financial data for ORIC Pharmaceuticals Inc. ( ORIC), the Return on Equity (ROE) stands at -48.45%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -44.76%, reflecting the company’s efficiency in generating profits from its assets. Additionally, ORIC Pharmaceuticals Inc’s Return on Invested Capital (ROIC) is -60.46%, showcasing its effectiveness in deploying capital for earnings.
ORIC Pharmaceuticals Inc (ORIC) Efficiency & Liquidity Metrics
Based on ORIC Pharmaceuticals Inc’s (ORIC) latest financial statements, the Debt-to-Equity Ratio is 0.01%, indicating its reliance on debt financing relative to shareholder equity.
ORIC Pharmaceuticals Inc (ORIC) Efficiency & Liquidity Metrics
From an operational efficiency perspective, ORIC Pharmaceuticals Inc. (ORIC) effectively leverages its workforce, generating an average of -$1155304.35 per employee. The company’s liquidity position is robust, with a Current Ratio of 12.00% and a Quick Ratio of 12.00%, indicating strong ability to cover short-term liabilities.
ORIC Pharmaceuticals Inc [ORIC]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ORIC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for ORIC Pharmaceuticals Inc go to 3.17%.
An analysis of Institutional ownership at ORIC Pharmaceuticals Inc [ORIC]
There are presently around $102.17%, or 110.94% of ORIC stock, in the hands of institutional investors. The top three institutional holders of ORIC stocks are: NEXTECH INVEST LTD. with ownership of 5.29 million shares, which is approximately 7.5136%. FMR LLC, holding 4.92 million shares of the stock with an approximate value of $$34.79 million in ORIC stocks shares; and FMR LLC, currently with $$34.15 million in ORIC stock with ownership which is approximately 6.8671%.
